Amneal Pharmaceuticals Settles Nationwide Opioid Claims for Up to $267M

jueves, 29 de enero de 2026, 11:27 am ET1 min de lectura
AMRX--

Amneal Pharmaceuticals has initiated a nationwide settlement for opioid-related claims, allowing claimants to receive up to $267M in cash and overdose treatments. The settlement, which takes effect on Thursday, resolves a majority of opioid-related claims against the company.

Amneal Pharmaceuticals Settles Nationwide Opioid Claims for Up to $267M

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios